Birdwatch Note Rating
2023-03-16 09:51:37 UTC - NOT_HELPFUL
Rated by Participant: C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details